Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $150.1600 (0.01%) ($148.8800 - $150.3500) on Mon. Aug. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.29% (three month average) | RSI | 59 | Latest Price | $150.1600(0.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.3% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(59%) DIA(52%) SPLV(51%) VYM(48%) IBB(47%) | Factors Impacting ABBV price | ABBV will decline at least -0.645% in a week (0% probabilities). VXX(-34%) VIXM(-32%) USO(-19%) TBT(-15%) BNDX(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.645% (StdDev 1.29%) | Hourly BBV | -0.8 () | Intraday Trend | 0.3% | | | |
|
5 Day Moving Average | $150.8(-0.42%) | 10 Day Moving Average | $151.02(-0.57%) | 20 Day Moving Average | $149.52(0.43%) | To recent high | -1.4% | To recent low | 13.3% | Market Cap | $264.925b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |